Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             157 results found
no title author magazine year volume issue page(s) type
1 Absence of effects of long-term growth hormone replacement therapy on insulin sensitivity in adults with growth hormone deficiency of childhood-onset (GHDA-CO) Knoepfelmacher, Mirta
 2003
 46-47 5 p. 295-302
8 p.
 article
2 Abstracts 1999
 46-47 5 p. 308-396
89 p.
 article
3 Acute and chronic effects of growth hormone on renal regulation of electrolyte and water homeostasis Dimke, Henrik
 2007
 46-47 5 p. 353-368
16 p.
 article
4 Administration of capsaicin and isoflavone promotes hair growth by increasing insulin-like growth factor-I production in mice and in humans with alopecia Harada, Naoaki
 2007
 46-47 5 p. 408-415
8 p.
 article
5 Aims ; Scope/Editorial Board 2003
 46-47 5 p. i-
1 p.
 article
6 Aims & Scope/Editorial Board 2009
 46-47 5 p. i-
1 p.
 article
7 Aims & Scope/Editorial Board 2005
 46-47 5 p. i-
1 p.
 article
8 Aims & Scope/Editorial Board 2007
 46-47 5 p. i-
1 p.
 article
9 Aims & Scope/Editorial Board 2008
 46-47 5 p. i-
1 p.
 article
10 Akt mediates insulin rescue from apoptosis in brown adipocytes: effect of ceramide Navarro, Paloma
 2000
 46-47 5 p. 256-266
11 p.
 article
11 A marked deficiency in circulating and renal IGF-I peptide does not inhibit compensatory renal enlargement in uninephrectomized mice Landau, Daniel
 2011
 46-47 5 p. 279-284
6 p.
 article
12 A nonsense mutation (E72X) in growth hormone releasing hormone receptor (GHRHR) gene is the major cause of familial isolated growth hormone deficiency in Western region of India: founder effect suggested by analysis of dinucleotide repeat polymorphism close to GHRHR gene Kamijo, Takashi
 2004
 46-47 5 p. 394-401
8 p.
 article
13 A novel bioassay based on human growth hormone (hGH) receptor mediated cell proliferation: measurement of 20K-hGH and its modified forms Ikeda, M.
 2000
 46-47 5 p. 248-255
8 p.
 article
14 A novel two-chain IGF-II-derived peptide from purified β-cell granules Buchanan, Christina M.
 2010
 46-47 5 p. 360-366
7 p.
 article
15 Association between birth weight, body mass index and IGF2/ApaI polymorphism Gomes, M.V.M.
 2005
 46-47 5 p. 360-362
3 p.
 article
16 Association between the ratio of insulin-like growth factor-I to insulin-like growth factor binding protein-3 and inflammation in incident automated peritoneal dialysis patients Lee, Mi Jung
 2013
 46-47 5 p. 170-174
5 p.
 article
17 Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6months — Results from a randomized clinical trial Rzehak, Peter
 2013
 46-47 5 p. 149-158
10 p.
 article
18 Attenuation of IGF-I receptor signaling inhibits serum-induced proliferation of prostate cancer cells Himpe, Eddy
 2011
 46-47 5 p. 252-259
8 p.
 article
19 Autosomal recessive form of isolated growth hormone deficiency is more frequent than the autosomal dominant form in a Brazilian cohort Lido, Andria C.V.
 2014
 46-47 5 p. 180-186
7 p.
 article
20 Behavioural phenotyping of male growth hormone-releasing hormone (GHRH) knockout mice Leone, Sheila
 2014
 46-47 5 p. 192-197
6 p.
 article
21 Bioequivalence studies for three formulations of a recombinant human growth hormone: Challenges and lessons learned Dao, Le
 2010
 46-47 5 p. 367-371
5 p.
 article
22 Cafeteria diet-induced obesity is associated with a low spontaneous growth hormone secretion and normal plasma insulin-like growth factor-I concentrations Schepper, J.A. De
 1998
 46-47 5 p. 397-401
5 p.
 article
23 Can IGF-I polymorphism affect power and endurance athletic performance? Ben-Zaken, Sigal
 2013
 46-47 5 p. 175-178
4 p.
 article
24 Changes in bone mineral density after discontinuation and early reinstitution of growth hormone (GH) in patients with childhood-onset GH deficiency Benbassat, Carlos A.
 1999
 46-47 5 p. 290-295
6 p.
 article
25 Changes in IGF-I, urinary free cortisol and adipokines during dronabinol therapy in anorexia nervosa: Results from a randomised, controlled trial Andries, Alin
 2015
 46-47 5 p. 247-252
6 p.
 article
26 Circulating asymmetric dimethylarginine and lipid profile in pre-pubertal children with growth hormone deficiency: Effect of 12-month growth hormone replacement therapy De Marco, S.
 2014
 46-47 5 p. 216-220
5 p.
 article
27 Clinical deterioration after cessation of growth hormone replacement therapy in a young adult with severe growth hormone deficiency Mönig, Heiner
 1998
 46-47 5 p. 385-387
3 p.
 article
28 Commencing growth hormone replacement in adults with a fixed low dose. Effects on serum lipoproteins, glucose metabolism, body composition, and cardiovascular function Gillberg, P.
 2001
 46-47 5 p. 273-281
9 p.
 article
29 Comparison of STAT5 mRNA levels in GH-treated male and female rats analysed by a solution hybridization assay Ortiz, B.L.
 2000
 46-47 5 p. 236-241
6 p.
 article
30 Comparison of two growth hormone stimulation tests and their cut-off limits in healthy adults at an outpatient clinic Markkanen, Helene M.
 2013
 46-47 5 p. 165-169
5 p.
 article
31 Concomitant, specific determination of growth hormone and pegvisomant in human serum Ørskov, H.
 2007
 46-47 5 p. 431-434
4 p.
 article
32 Cortistatin-17 and -14 exert the same endocrine activities as somatostatin in humans Gottero, C.
 2004
 46-47 5 p. 382-387
6 p.
 article
33 Crosstalk between the TNF and IGF pathways enhances NF-κB activation and signaling in cancer cells Li, Shun
 2015
 46-47 5 p. 253-261
9 p.
 article
34 Dendritic stability in a model of adult-onset IGF-I deficiency Grill, Joshua D.
 2005
 46-47 5 p. 337-348
12 p.
 article
35 Desacyl ghrelin is influenced by changes in insulin concentration during an insulin tolerance test Blijdorp, K.
 2013
 46-47 5 p. 193-195
3 p.
 article
36 Detection of His-tagged Long-R3-IGF-I in a black market product Kohler, Maxie
 2010
 46-47 5 p. 386-390
5 p.
 article
37 Developmental changes and the impact of isoflavones on mRNA expression of IGF-I receptor, EGF receptor and related growth factors in porcine skeletal muscle cell cultures Kalbe, Claudia
 2008
 46-47 5 p. 424-433
10 p.
 article
38 Diabetic osteopathy and the IGF system in the Goto–Kakizaki rat Ahmad, Tashfeen
 2008
 46-47 5 p. 404-411
8 p.
 article
39 Diagnosis and management of growth hormone deficiency in childhood and adolescence – Part 2: Growth hormone treatment in growth hormone deficient children Tanaka, Toshiaki
 2002
 46-47 5 p. 323-341
19 p.
 article
40 Dietary conjugated linoleic acid increases PPARγ gene expression in adipose tissue of obese rat, and improves insulin resistance Zhou, Xiao-Rong
 2008
 46-47 5 p. 361-368
8 p.
 article
41 Differential regulation of pregnancy associated plasma protein (PAPP)-A during pregnancy in human and mouse Qin, Xuezhong
 2002
 46-47 5 p. 359-366
8 p.
 article
42 Dihydrotestosterone inhibits hair growth in mice by inhibiting insulin-like growth factor-I production in dermal papillae Zhao, Juan
 2011
 46-47 5 p. 260-267
8 p.
 article
43 Distribution and morphology of the juxtapositions between growth hormone-releasing hormone-(ghrh)-immunoreactive neuronal elements Anderson, Daniel
 2010
 46-47 5 p. 356-359
4 p.
 article
44 Echocardiographic assessment of cardiac morphology and function in mutant dwarf rats Longobardi, S.
 2000
 46-47 5 p. 242-247
6 p.
 article
45 Editorial Le Roith, D.
 1999
 46-47 5 p. 279-
1 p.
 article
46 Editorial Board 2010
 46-47 5 p. i-
1 p.
 article
47 Editorial Board 2013
 46-47 5 p. i-
1 p.
 article
48 Editorial board 2004
 46-47 5 p. i-
1 p.
 article
49 Editorial board 2002
 46-47 5 p. i-
1 p.
 article
50 Editorial Board 2014
 46-47 5 p. i-
1 p.
 article
51 editorial Board 2015
 46-47 5 p. i-
1 p.
 article
52 Editorial Board 2011
 46-47 5 p. i-
1 p.
 article
53 Editorial Board 2012
 46-47 5 p. i-
1 p.
 article
54 Editorial review: the case of local versus endocrine IGF-I actions: the jury is still out D'Ercole, A.J.
 2001
 46-47 5 p. 261-265
5 p.
 article
55 Effect of aging on growth hormone-induced insulin-like growth factor-I secretion from cultured rat chondrocytes Rousseau, N.
 1998
 46-47 5 p. 403-409
7 p.
 article
56 Effect of high- and low-intensity exercise and metabolic acidosis on levels of GH, IGF-I, IGFBP-3 and cortisol Wahl, Patrick
 2010
 46-47 5 p. 380-385
6 p.
 article
57 Effects of combined hormone replacement therapy or its effective agents on the IGF-1 pathway in skeletal muscle Pöllänen, Eija
 2010
 46-47 5 p. 372-379
8 p.
 article
58 Effects of insulin-like growth factor-I on cultured human coronary artery smooth muscle cells Bayes-Genis, Antoni
 2003
 46-47 5 p. 246-253
8 p.
 article
59 Effects of rGH and G118RrGH on the induction of CYP2C12 and IGF-I in primary rat hepatocytes Helander, Hanna
 2003
 46-47 5 p. 287-294
8 p.
 article
60 Efficacy and safety of individualized growth hormone treatment in adult Japanese patients with growth hormone deficiency Chihara, Kazuo
 2008
 46-47 5 p. 394-403
10 p.
 article
61 Electronic publishing-lessons learned Sonsken, Peter
 1998
 46-47 5 p. 361-
1 p.
 article
62 Elevated insulin-like growth factor 2 expression may contribute to the hypermuscular phenotype of myostatin null mice Clark, Daniel L.
 2015
 46-47 5 p. 207-218
12 p.
 article
63 Evaluation of the association between GHR exon 3 polymorphism and polycystic ovary syndrome among Han Chinese women Shen, Yun
 2011
 46-47 5 p. 248-251
4 p.
 article
64 Evidence for two distinct classes of high affinity growth hormone binding proteins in pregnant rat serum Ymer, S.I.
 2000
 46-47 5 p. 275-289
15 p.
 article
65 Exercise capacity and hormonal response in adults with childhood onset growth hormone deficiency during long-term somatropin treatment Gullestad, Lars
 1998
 46-47 5 p. 377-384
8 p.
 article
66 Experimental arthritis: Effect on growth parameters and total skeletal calcium Pozo, E. del
 2009
 46-47 5 p. 442-446
5 p.
 article
67 Expression of insulin-like growth factor-I and insulin-like growth factor binding proteins during thioacetamide-induced liver cirrhosis in rats Novosyadlyy, R.
 2005
 46-47 5 p. 313-323
11 p.
 article
68 Female recruits sustaining stress fractures during military basic training demonstrate differential concentrations of circulating IGF-I system components: A preliminary study Strohbach, C.A.
 2012
 46-47 5 p. 151-157
7 p.
 article
69 Free insulin-like growth factors – measurements and relationships to growth hormone secretion and glucose homeostasis Frystyk, Jan
 2004
 46-47 5 p. 337-375
39 p.
 article
70 Functional maturation of growth hormone cells in the anterior pituitary gland of the fetus Nogami, Haruo
 2008
 46-47 5 p. 379-388
10 p.
 article
71 GHR exon 3 polymorphism: Association with type 2 diabetes mellitus and metabolic disorder Strawbridge, R.J.
 2007
 46-47 5 p. 392-398
7 p.
 article
72 Growth and maturational changes in dense fibrous connective tissue following 14 days of rhGH supplementation in the dwarf rat Kyparos, Antonios
 2002
 46-47 5 p. 367-373
7 p.
 article
73 Growth hormone and growth hormone secretagogue effects on nitrogen balance and urea synthesis in steroid treated rats Aagaard, Niels Kristian
 2009
 46-47 5 p. 426-431
6 p.
 article
74 Growth hormone deficiency in one of two siblings with Fanconi’s anaemia complementation group FA-D Schoof, E.
 2000
 46-47 5 p. 290-293
4 p.
 article
75 Growth hormone enhances proinflammatory cytokine production by monocytes in whole blood Uronen-Hansson, H.
 2003
 46-47 5 p. 282-286
5 p.
 article
76 Growth hormone (GH) is a survival rather than a proliferative factor for embryonic striatal neural precursor cells Regalado-Santiago, Citlalli
 2013
 46-47 5 p. 179-186
8 p.
 article
77 Growth hormone induces myocardial expression of creatine transporter and decreases plasma levels of IL-1β in rats during early postinfarct cardiac remodeling Omerovic, Elmir
 2003
 46-47 5 p. 239-245
7 p.
 article
78 Growth hormone replacement throughout life: Insights into age-related responses to treatment Clayton, Peter
 2007
 46-47 5 p. 369-382
14 p.
 article
79 Growth hormone responses to acute resistance exercise with vascular restriction in young and old men Manini, Todd M.
 2012
 46-47 5 p. 167-172
6 p.
 article
80 Growth hormone responses to sub-maximal and sprint exercise Stokes, Keith
 2003
 46-47 5 p. 225-238
14 p.
 article
81 Growth hormone status predicts left ventricular mass in patients after cure of acromegaly Wexler, Tamara L.
 2010
 46-47 5 p. 333-337
5 p.
 article
82 hGH isoform differential immunoassays applied to blood samples from athletes: Decision limits for anti-doping testing Hanley, James A.
 2014
 46-47 5 p. 205-215
11 p.
 article
83 High-dose erythropoietin inhibits apoptosis and stimulates proliferation in neonatal rat intestine McPherson, Ronald J.
 2007
 46-47 5 p. 424-430
7 p.
 article
84 Honorary members 2005
 46-47 5 p. 311-312
2 p.
 article
85 Identification of differentially expressed genes in the kidneys of growth hormone transgenic mice Coschigano, K.T.
 2010
 46-47 5 p. 345-355
11 p.
 article
86 IGFBP-3: A cell fate pivot in cancer and disease Johnson, Michael A.
 2014
 46-47 5 p. 164-173
10 p.
 article
87 IGF-I sensitivity in Silver–Russell syndrome with IGF2/H19 hypomethylation Iliev, D.I.
 2014
 46-47 5 p. 187-191
5 p.
 article
88 IGF-I signalling in bone growth: Inhibitory actions of dexamethasone and IL-1β MacRae, Vicky E.
 2007
 46-47 5 p. 435-439
5 p.
 article
89 Impact of hypoxia on IGF-I, IGF-II, IGFBP-3, ALS and IGFBP-1 regulation and on IGF1R gene expression in children Custodio, Rodrigo José
 2012
 46-47 5 p. 186-191
6 p.
 article
90 Impact of moderate interval exercise versus supine rest on the pharmacokinetics and pharmacodynamic profiles of subcutaneously administered growth hormone in adult growth hormone deficient patients Janukonytė, J.
 2014
 46-47 5 p. 198-204
7 p.
 article
91 Impact of targeting insulin-like growth factor signaling in head and neck cancers Limesand, Kirsten H.
 2013
 46-47 5 p. 135-140
6 p.
 article
92 Impaired brain development and hydrocephalus in a line of transgenic mice with liver-specific expression of human insulin-like growth factor binding protein-1 Doublier, S.
 2000
 46-47 5 p. 267-274
8 p.
 article
93 Inflammatory cytokines in juvenile idiopathic arthritis: Effects on physical growth and the insulin-like-growth factor axis Wong, S.C.
 2008
 46-47 5 p. 369-378
10 p.
 article
94 Influence of pre-analytical conditions on the measurement of components of the GH/IGF axis in rats Bielohuby, Maximilian
 2013
 46-47 5 p. 141-148
8 p.
 article
95 Influence of the crosstalk between growth hormone and insulin signalling on the modulation of insulin sensitivity Dominici, Fernando P.
 2005
 46-47 5 p. 324-336
13 p.
 article
96 In memory of Francesco Maria Minuto Ferone, Diego
 2014
 46-47 5 p. 155-156
2 p.
 article
97 Instability of IGF–IGFBP complex as a cause of the different performance of serum and EDTA-plasma after storage: EDTA-plasma is preferable for evaluating bioactive IGF especially in the mouse Setoyama, Takeshi
 2015
 46-47 5 p. 227-231
5 p.
 article
98 Insulin-like growth factor (IGF)-I and IGF-II contribute differentially to the phenotype of pregnancy associated plasma protein-A knock-out mice Mason, Emily J.
 2011
 46-47 5 p. 243-247
5 p.
 article
99 Intracellular signaling by growth hormone variant (GH-V) Silva, Corinne M
 2002
 46-47 5 p. 374-380
7 p.
 article
100 IRS-1 expression and activation are not sufficient to activate downstream pathways and enable IGF-I growth response in estrogen receptor negative breast cancer cells Jackson, James G.
 1999
 46-47 5 p. 280-289
10 p.
 article
101 Isolated growth hormone (GH) deficiency in adult patients: Baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database Abs, Roger
 2005
 46-47 5 p. 349-359
11 p.
 article
102 Lactogenic hormone responsive element reporter gene activation assay for human growth hormone Sakatani, T.
 2003
 46-47 5 p. 275-281
7 p.
 article
103 Ligand blotting: iodinated vs biotinylated IGF Shalamanova, Liliana
 2000
 46-47 5 p. 294-
1 p.
 article
104 Long-term effects of growth hormone replacement therapy on liver function in adult patients with growth hormone deficiency Matsumoto, Ryusaku
 2014
 46-47 5 p. 174-179
6 p.
 article
105 More concerns and stronger beliefs about the necessity of medication in patients with acromegaly are associated with negative illness perceptions and impairment in quality of life Andela, Cornelie D.
 2015
 46-47 5 p. 219-226
8 p.
 article
106 New N-terminal located mutation (Q4ter) within the POU1F1-gene (PIT-1) causes recessive combined pituitary hormone deficiency and variable phenotype Salemi, Souzan
 2003
 46-47 5 p. 264-268
5 p.
 article
107 Nonalcoholic fatty liver in patients with Laron syndrome and GH gene deletion – Preliminary report Laron, Zvi
 2008
 46-47 5 p. 434-438
5 p.
 article
108 Normal size of the lumen of the aorta in dwarf mice lacking IGF-II Zaina, S.
 2001
 46-47 5 p. 298-302
5 p.
 article
109 Optimizing IGF-I for skeletal muscle therapeutics Philippou, Anastassios
 2014
 46-47 5 p. 157-163
7 p.
 article
110 Ovariectomy and gonadal hormone treatment: effects on insulin-like growth factor-1 receptors in the rat brain El-Bakri, Nahid K.
 2004
 46-47 5 p. 388-393
6 p.
 article
111 Pappa2 deletion alters IGFBPs but has little effect on glucose disposal or adiposity Christians, Julian K.
 2015
 46-47 5 p. 232-239
8 p.
 article
112 PEGylation enhances the therapeutic potential for insulin-like growth factor I in central nervous system disorders Saenger, S.
 2011
 46-47 5 p. 292-303
12 p.
 article
113 Pharmacokinetics and acute lipolytic actions of growth hormone Hansen, Troels Krarup
 2002
 46-47 5 p. 342-358
17 p.
 article
114 Prediction of improvement in quality of life (QoL-AGHDA) in adults with growth hormone deficiency by normative reference limits: Data of the German KIMS cohort Moock, Joern
 2011
 46-47 5 p. 272-278
7 p.
 article
115 Prevalence of discordant GH and IGF-I levels in acromegalics at diagnosis, after surgical treatment and during treatment with octreotide LAR® Machado, Evelyn Oliveira
 2008
 46-47 5 p. 389-393
5 p.
 article
116 Programme 1999
 46-47 5 p. 299-306
8 p.
 article
117 Reduced colonic apoptosis in mice overexpressing bovine growth hormone occurs through changes in several kinase pathways Bogazzi, Fausto
 2009
 46-47 5 p. 432-441
10 p.
 article
118 Reduced susceptibility to azoxymethane-induced aberrant crypt foci formation and colon cancer in growth hormone deficient rats Carroll, Robert E.
 2009
 46-47 5 p. 447-456
10 p.
 article
119 Regulation of GHRH receptor gene expression in the neonatal and adult rat pituitary Korytko, A.I.
 2001
 46-47 5 p. 282-288
7 p.
 article
120 Regulation of IGF binding proteins in human aorta vascular smooth muscle cells by cAMP, dexamethasone and IGF-I Hayford, K.
 1998
 46-47 5 p. 369-375
7 p.
 article
121 Regulation of interleukin-8 expression in human prostate cancer cells by insulin-like growth factor-I and inflammatory cytokines Kooijman, Ron
 2007
 46-47 5 p. 383-391
9 p.
 article
122 Regulation of the splenic somatotropic axis by dietary protein and insulin-like growth factor-I in the rat Mejia-Naranjo, Wilson
 2003
 46-47 5 p. 254-263
10 p.
 article
123 Relationship between growth hormone in vivo bioactivity, the insulin-like growth factor-I system and bone mineral density in young, physically fit men and women Nindl, B.C.
 2008
 46-47 5 p. 439-445
7 p.
 article
124 Relative localization of the prolactin receptor binding sites for lactogenic hormones Longhi, S.A.
 2001
 46-47 5 p. 324-328
5 p.
 article
125 Responses of insulin-like growth factor (IGF)-I and IGF-binding proteins to nutritional status in peroxisome proliferator-activated receptor-alpha knockout mice Lewitt, M.S.
 2001
 46-47 5 p. 303-313
11 p.
 article
126 Role of IRS-1 and SHC activation in 3T3-L1 fibroblasts differentiation Laurino, C.
 1998
 46-47 5 p. 363-367
5 p.
 article
127 Schedule 1999
 46-47 5 p. 307-
1 p.
 article
128 Scientific Organizing Committee 1999
 46-47 5 p. 297-298
2 p.
 article
129 Serum IGF-I and C-reactive protein in healthy black and white young men: The CARDIA male hormone study Colangelo, Laura A.
 2009
 46-47 5 p. 420-425
6 p.
 article
130 Serum insulin-like growth factor-I is negatively associated with serum adiponectin in type 2 diabetes mellitus Kanazawa, Ippei
 2011
 46-47 5 p. 268-271
4 p.
 article
131 Serum visfatin levels in acromegaly: Correlation with disease activity and metabolic alterations Ciresi, A.
 2015
 46-47 5 p. 240-246
7 p.
 article
132 Severe deficiencies of IGF-I, IGF-II, IGFBP-3, ALS and paradoxically high-normal bone mass in a child with insulin-resistance syndrome (Rabson-Mendenhall type) Fowlkes, J.L.
 2007
 46-47 5 p. 399-407
9 p.
 article
133 Somatostatin analog treatment is associated with an increased sleep latency in patients with long-term biochemical remission of acromegaly Klaauw, Agatha A. van der
 2008
 46-47 5 p. 446-453
8 p.
 article
134 Specific interactions of growth hormone (GH) with GH-receptors and GH-binding proteins in vivo in genetically GH-deficient Ames dwarf mice Turyn, D.
 1998
 46-47 5 p. 389-396
8 p.
 article
135 Status of long-acting-growth hormone preparations — 2015 Høybye, Charlotte
 2015
 46-47 5 p. 201-206
6 p.
 article
136 Stimulation of hepatocyte growth factor production by ascorbic acid and its stable 2-glucoside Wu, Y.L.
 1998
 46-47 5 p. 421-428
8 p.
 article
137 Systemic treatment with epidermal growth factor causes organ growth concomitant with reduced circulating levels of IGF-I and IGFBP-3: time-dependent changes in female rats Vinter-Jensen, L.
 1998
 46-47 5 p. 411-419
9 p.
 article
138 The acute effect of a single application of cabergoline on endogenous GH levels in patients with acromegaly on pegvisomant treatment Roemmler, J.
 2010
 46-47 5 p. 338-344
7 p.
 article
139 The association between growth response to growth hormone and baseline body composition of children with growth hormone deficiency Esen, Ihsan
 2013
 46-47 5 p. 196-199
4 p.
 article
140 The atypical α2β2 IGF receptor expressed in inducible c2.7 myoblasts is derived from post-translational modifications of the mouse IGF-I receptor Navarro, Magali
 2008
 46-47 5 p. 412-423
12 p.
 article
141 The cardiovascular phenotype of a mouse model of acromegaly Izzard, Ashley S.
 2009
 46-47 5 p. 413-419
7 p.
 article
142 The effect of growth hormone on insulin-like growth factor I and bone metabolism in distraction osteogenesis Bail, H.J.
 2001
 46-47 5 p. 314-323
10 p.
 article
143 The effect of insulin-like growth factor-I on production of vascular endothelial growth factor by amnion-derived (WISH) cells Kawano, Yasushi
 2004
 46-47 5 p. 376-381
6 p.
 article
144 The effects of type 1 IGF receptor inhibition in a mouse model of diabetic kidney disease Troib, Ariel
 2011
 46-47 5 p. 285-291
7 p.
 article
145 The First International Standard for Insulin-like Growth Factor-1 (IGF-1) for immunoassay: Preparation and calibration in an international collaborative study Burns, C.
 2009
 46-47 5 p. 457-462
6 p.
 article
146 The frontal cortex IGF system is down regulated in the term, intrauterine growth restricted fetal baboon Xie, L.
 2013
 46-47 5 p. 187-192
6 p.
 article
147 The growth hormone-insulin-like growth factor axis in adult patients with Prader Willi syndrome Höybye, Charlotte
 2003
 46-47 5 p. 269-274
6 p.
 article
148 The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation of adult rats Andersen, N.B.
 2001
 46-47 5 p. 266-272
7 p.
 article
149 The insulin-like growth factor mutation database (IGFmdb) Rajapaksha, Harinda
 2012
 46-47 5 p. 158-166
9 p.
 article
150 Total pubertal growth in patients with juvenile idiopathic arthritis treated with growth hormone: Analysis of a single center Bechtold, S.
 2012
 46-47 5 p. 180-185
6 p.
 article
151 Transcriptional regulation of IGF-I receptor gene expression by the PAX3–FKHR oncoprotein Ayalon, D.
 2001
 46-47 5 p. 289-297
9 p.
 article
152 Transgenic overexpression of pregnancy-associated plasma protein-A in skeletal muscle of mice increases myofiber size and central nucleation in sedentary muscle and promotes muscle regeneration in the injured muscle Deb, Chandra
 2012
 46-47 5 p. 173-179
7 p.
 article
153 Truncated somatostatin receptor 5 may modulate therapy response to somatostatin analogues — Observations in two patients with acromegaly and severe headache Marina, Djordje
 2015
 46-47 5 p. 262-267
6 p.
 article
154 Two phenotypes of arthropathy in long-term controlled acromegaly? A comparison between patients with and without joint space narrowing (JSN) Claessen, K.M.J.A.
 2013
 46-47 5 p. 159-164
6 p.
 article
155 Unexpected and unexplained phenotypes in transgenic models Murphy, Liam J.
 2000
 46-47 5 p. 233-235
3 p.
 article
156 Validation of the growth hormone (GH)-dependent marker method of detecting GH abuse in sport through the use of independent data sets Erotokritou-Mulligan, Ioulietta
 2007
 46-47 5 p. 416-423
8 p.
 article
157 What's new in the IGF-binding proteins? Rosenzweig, Steven A.
 2004
 46-47 5 p. 329-336
8 p.
 article
                             157 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands